The FDA announced on August 13, 2015, that GlaxoSmithKline LLC voluntarily recalled Bactroban Ointment due to penicillin cross-contamination and foreign substances. Owners should contact the company for a refund.
How to tell if you have it
- Brand: Bactroban
- Product: Bactroban Ointment 2% Tube
- NDC: 0029-1525-44
- Lot #: C698039
- Expiration: 03/2016
The hazard
The product was contaminated with penicillin and foreign substances during the manufacturing process, according to the FDA. The recall involves 19,520 tubes distributed nationwide and in Puerto Rico.
Context
GovInfoNow's records show GlaxoSmithKline LLC has had 11 other recalls since October 8, 2012. Other recent recalls of similar products include Tivicay PD Recall (May 17, 2024), GlaxoSmithKline ANORO ELLIPTA inhaler recall (December 12, 2023), and GlaxoSmithKline Tivicay Tablets recall (May 13, 2022). Other recent recalls of similar products include Dabur Med Pride Bacitracin Zinc Ointment Recall (June 2, 2026) and Golden State Baclofen Tablets Recall (November 26, 2025).